BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31407091)

  • 1. An Exploratory Analysis of Fecal Immunochemical Test Performance for Colorectal Cancer Screening in Nigeria.
    Knapp GC; Sharma A; Olopade B; Alatise OI; Olasehinde O; Arije OO; Castle PE; Kingham TP
    World J Surg; 2019 Nov; 43(11):2674-2680. PubMed ID: 31407091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and performance of the fecal immunochemical test (FIT) for average-risk colorectal cancer screening in Nigeria.
    Knapp GC; Alatise O; Olopade B; Samson M; Olasehinde O; Wuraola F; Odujoko OO; Komolafe AO; Arije OO; Castle PE; Smith JJ; Weiser MR; Kingham TP
    PLoS One; 2021; 16(1):e0243587. PubMed ID: 33434195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fresh vs Frozen Samples and Ambient Temperature Have Little Effect on Detection of Colorectal Cancer or Adenomas by a Fecal Immunochemical Test in a Colorectal Cancer Screening Cohort in Germany.
    Chen H; Werner S; Brenner H
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1547-1556.e5. PubMed ID: 27793749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program.
    Gibson DJ; Mooney T; Mooney J; Mulcahy HE; O'Donoghue D
    Gastrointest Endosc; 2019 Mar; 89(3):518-522. PubMed ID: 30142350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial.
    van Roon AH; Hol L; van Vuuren AJ; Francke J; Ouwendijk M; Heijens A; Nagtzaam N; Reijerink JC; van der Togt AC; van Ballegooijen M; Kuipers EJ; van Leerdam ME
    Am J Gastroenterol; 2012 Jan; 107(1):99-107. PubMed ID: 22108450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable hemoglobin concentration with fecal immunochemical test at high temperatures in a Caribbean colorectal cancer screening program.
    Blake SN; Kortlever TL; Verbrugge SE; van Vuuren AJ; Dekker E; van der Vlugt M; Hugtenburg JG
    Clin Chim Acta; 2024 Jun; 560():119723. PubMed ID: 38735515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT).
    Allison JE; Fraser CG; Halloran SP; Young GP
    Gut Liver; 2014 Mar; 8(2):117-30. PubMed ID: 24672652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Colorectal Cancer Screening Appropriate in Nigeria?
    Knapp GC; Alatise OI; Olasehinde OO; Adeyeye A; Ayandipo OO; Weiser MR; Kingham TP
    J Glob Oncol; 2019 Jun; 5():1-10. PubMed ID: 31170018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Imperfect Compliance With Instructions for Fecal Sample Collection on Diagnostic Performance of 9 Fecal Immunochemical Tests.
    Gies A; Gruner LF; Schrotz-King P; Brenner H
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1829-1839.e4. PubMed ID: 30851476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase.
    Caviglia GP; Cabianca L; Fagoonee S; Gili FM
    Biochem Med (Zagreb); 2016; 26(1):114-20. PubMed ID: 26981025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening.
    Gies A; Cuk K; Schrotz-King P; Brenner H
    Clin Transl Gastroenterol; 2018 Jul; 9(7):168. PubMed ID: 29976921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer screening with the fecal immunochemical test in persons aged 30 to 49 years: focusing on the age for commencing screening.
    Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
    Gastrointest Endosc; 2017 Nov; 86(5):892-899. PubMed ID: 28385585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.
    Dominitz JA; Robertson DJ; Ahnen DJ; Allison JE; Antonelli M; Boardman KD; Ciarleglio M; Del Curto BJ; Huang GD; Imperiale TF; Larson MF; Lieberman D; O'Connor T; O'Leary TJ; Peduzzi P; Provenzale D; Shaukat A; Sultan S; Voorhees A; Wallace R; Guarino PD
    Am J Gastroenterol; 2017 Nov; 112(11):1736-1746. PubMed ID: 29016565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
    Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Immunochemical Test: The World's Colorectal Cancer Screening Test.
    Robertson DJ; Selby K
    Gastrointest Endosc Clin N Am; 2020 Jul; 30(3):511-526. PubMed ID: 32439085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening.
    Shapiro JA; Bobo JK; Church TR; Rex DK; Chovnick G; Thompson TD; Zauber AG; Lieberman D; Levin TR; Joseph DA; Nadel MR
    Am J Gastroenterol; 2017 Nov; 112(11):1728-1735. PubMed ID: 29016558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
    Robertson DJ; Lee JK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Lieberman D; Levin TR; Rex DK
    Gastroenterology; 2017 Apr; 152(5):1217-1237.e3. PubMed ID: 27769517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Colorectal Cancer Screening in Detecting Earlier-Stage Disease-A Nationwide Cohort Study in Denmark.
    Larsen MB; Njor S; Ingeholm P; Andersen B
    Gastroenterology; 2018 Jul; 155(1):99-106. PubMed ID: 29626451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia.
    Kapidzic A; van der Meulen MP; Hol L; van Roon AH; Looman CW; Lansdorp-Vogelaar I; van Ballegooijen M; van Vuuren AJ; Reijerink JC; van Leerdam ME; Kuipers EJ
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1464-71.e4. PubMed ID: 25724706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.